InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Mehta Vimal, CEO, Président et secrétaire. Officer active across 1 company, notably BioXcel Therapeutics, Inc.. In total, 24 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €12.4m. Activity tracked since 25 June 2021. The latest transaction was disclosed on 20 May 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Mehta Vimal
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
219 sharesCommon StockSEC:0001104659-26-075298:0
49,758 sharesCommon StockSEC:0001104659-26-065836:0
19,419 shares@ US$1.0870.059% mcap0.1% of flowCommon StockSEC:0001104659-26-065836:1
164 sharesCommon StockSEC:0001104659-26-028722:0
164 sharesCommon StockSEC:0001104659-25-121304:0
163 sharesCommon StockSEC:0001104659-25-090518:0
219 sharesCommon StockSEC:0001104659-25-090518:1
15,625 sharesCommon StockSEC:0001104659-25-069703:0
163 sharesCommon StockSEC:0001104659-25-059980:0
162 sharesCommon StockSEC:0001104659-25-024531:0
2,610 sharesCommon StockSEC:0001104659-24-129462:0
2,609 sharesCommon StockSEC:0001104659-24-100751:0
2,609 sharesCommon StockSEC:0001104659-24-072999:0
609,221 sharesCommon StockSEC:0001104659-24-069195:0
2,610 sharesCommon StockSEC:0001104659-24-044861:0
2,609 sharesCommon StockSEC:0001104659-23-126924:0
2,610 sharesCommon StockSEC:0001104659-23-101635:0
2,609 sharesCommon StockSEC:0001104659-23-072396:0
6,500 shares@ US$25.79090.6% of flowCommon StockSEC:0001104659-23-064163:0
15,000 sharesCommon StockSEC:0001104659-23-061539:0
30,000 shares@ US$0.410.0% of flowCommon StockSEC:0001104659-23-035711:0
10,437 sharesCommon StockSEC:0001104659-23-033403:0
30,000 shares@ US$0.410.0% of flowCommon StockSEC:0001104659-22-128367:0
473,250 shares@ US$30.828398.4% of flowCommon StockSEC:0001104659-21-086948:0
24 of 24 declarations
About Mehta Vimal
Mehta Vimal is CEO, Président et secrétaire of BioXcel Therapeutics, Inc. He has 24 filings in total, and in the sampled recent filings, all linked to BioXcel Therapeutics, Inc., there were only sales for EUR 12402134 between 2021-06-29 and 2026-06-17. The modal transaction nature is Levée d'options.
